Medical/Pharmaceuticals
Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints
SINGAPORE, July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusiveAsia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. ...
2021-07-01 08:00
3837
Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines
Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global markets MENLO PARK, Calif., June 30, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation ...
2021-06-30 20:00
1580
Mentice receives order of total SEK 5.9 million from Baylis Medical Company
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement withBaylis Medical Company ("Baylis")to provide simulation solutions. Based on t...
2021-06-30 18:19
1176
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) * Pending conditional regulatory approvals, Clover expects to commence product launch of SCB-2019 (CpG 1018/Alum) by the end of 2021 CHENGDU,...
2021-06-30 16:00
4214
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility
* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022 * Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data, potential payments upon...
2021-06-30 16:00
1971
Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions,appoints Gunilla Andersson as CFO, effective September 1st, 2021. Mentice AB is pleased to announce the appoin...
2021-06-30 15:06
1307
Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Airlines has approved the Envirotainer Releye® RLP for usage on their aircrafts. With this approval, China Airlines ...
2021-06-30 14:48
1648
Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease
Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations BRISTOL, England, June 30, 2021 /PRNewswire/ -- Bioinduction Ltd., a company developing an innovative and disruptive patient-centric Deep Brain Stimulation (DBS) platform s...
2021-06-30 14:00
1127
New Welch Allyn® PanOptic™ Plus Ophthalmoscope and Welch Allyn® MacroView® Plus Otoscope Give Caregivers Better, Bolder, Brighter Views
SINGAPORE, June 30, 2021 /PRNewswire/ -- Hillrom today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™ Plus Ophthalmoscope and the Welch Allyn® MacroView® Plus Otoscope. The new devices represent advancements...
2021-06-30 09:15
3589
Subcutaneously Injected PD-L1 Antibody Envafolimab (KN035) Obtained Its Second Orphan Drug Designation From The U.S. FDA
SUZHOU, China, June 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to envafolimab (KN035), a recombinant humanized PD-L1 single-domain antibody independently invented by Alphamab Onco...
2021-06-30 08:55
8392
GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)
* GSK Singapore has signed an Advance Purchase Agreement with the Government ofSingapore for sotrovimab * Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization * Announcement follow...
2021-06-30 06:30
2331
Cynosure Celebrates 30 Years of Innovation
Aesthetics leader recognizes milestone with focus on future skin aesthetics innovation to help reveal the Beautiful Energy within everyone WESTFORD, Mass., June 29, 2021 /PRNewswire/ -- Since 1991, Cynosure has been a leader in the beauty aesthetics space, creating a comprehensive range of exper...
2021-06-29 21:00
1727
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients BRUSSELS and CASTRES, France, June 29, 2021 /PRNewswire/ -- European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic part...
2021-06-29 20:13
1532
4G Clinical Announces $230MM Growth Equity Investment Backed by Goldman Sachs Asset Management
The innovative RTSM leader grew over 100% in 2020, plans to accelerate global expansion and support critical demand for products and services WELLESLEY, Mass. and NEW YORK, June 29, 2021 /PRNewswire/ -- 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, announc...
2021-06-29 20:00
1440
Medical Affairs Teams are Increasingly Turning to Patient-centric Analytics to Improve Clinical Outcomes
SANTA CLARA, Calif., June 29, 2021 /PRNewswire/ -- The shift to value-based care relies heavily on evidence-based medicine, and pharmaceutical companies play an important role in scientific communication across the healthcare ecosystem. Medical affairs experts interact with healthcare professiona...
2021-06-29 18:02
1128
Seegene unveils "MOBILE STATION," for on-site routine testing at public-use facilities and communities
* Seegene unveils "MOBILE STATION" at the Medlab Middle East 2021 * Mobile laboratory designed for mass testing at schools, airports, or communities, delivering test results within 3h 30min with the maximum testing capacity of 7,500 a day * The biotechnology firm to sign an MOU with G42 Heal...
2021-06-29 18:00
1523
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
SAN FRANCISCO and SUZHOU, China, June 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-29 08:00
4561
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2021
Added 19,367 New Subscribers in 4Q21 Revenues Up 0.8% YoY to RMB302.3 million ($46.1 million) Net Income Attributable Up 31.7% YoY to RMB127.7 million ($19.5 million) Operating Cash Flow Up 134.6% YoY to RMB211.1 million ($32.2 million) Conference Call to be Held on June 29, 2021 at 8:00 a.m. ET HO...
2021-06-29 04:16
22386
Pulnovo Medical: a Pulmonary Arterial Hypertension medical device company completed the world's first pulmonary hypertension treatment device RCT study after achieving FDA Breakthrough designation.
NANJING, China, June 28, 2021 /PRNewswire/ -- Recently, Pulnovo Medical's PADN-CFDA clinical trial, the world's first pulmonary hypertension treatment device RCT study, has completed all patients enrollment, and will continue to assist each enrollment center to complete the follow-up of enrolled ...
2021-06-28 21:16
1757
New Late-Breaking Data at The American Diabetes Association Show GlycoMark® May Be an Effective Test for COVID-19 Severity
RALEIGH, N.C. and SAN SEBASTIAN, Spain, June 28, 2021 /PRNewswire/ -- Precision Diabetes, Inc. and Patia announced today results from a study showing that the GlycoMark blood test may be an effective marker of stress hyperglycemia and severity in COVID-19 patients, particularly in patients withou...
2021-06-28 19:00
993
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 327 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 311 media titles]
2024-05-20 13:48
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 278 media titles]
2024-05-16 09:39
Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
12807
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
11515
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
10824
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
9635
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
2024-05-17 07:00
9150